ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Sunlenca, Injektionslösung - 2
68385001 Gilead Sciences Switzerland Sàrl
Sunlenca, Injektionslösung07.07.2023
  07.07.2023
Lenacapavir (J05AX31) 
WHO-DDD06.07.2028
08.03.2
08.03. 
A  
Yes 
IPCI
19883.88Yes
    
10 %20708.65
  
7680683850012Synthetika
  
Composition
lenacapavirum 463.5 mg ut lenacapavirum natricum, macrogolum 300, aqua ad iniectabile, ad solutionem pro 1.5 ml corresp. natrium 10.99 mg.
Packungsbestandteile
Injection solution 
  
 
Active AgentDose
Lenacapavirum463.5mg / 1.5ml
BAG: Active AgentDose
Lenacapavirum463.5 mg
 
Inactive agentsDose
Macrogol300
 
Source
Data was imported : 08.08.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home